Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage. [electronic resource]
Producer: 19980908Description: E2 p. digitalISSN:- 1098-4275
- Adrenal Cortex Hormones -- therapeutic use
- Brain -- drug effects
- Cerebral Hemorrhage -- diagnostic imaging
- Cerebral Palsy -- diagnostic imaging
- Confounding Factors, Epidemiologic
- Echoencephalography
- Female
- Humans
- Hypertension -- drug therapy
- Infant, Newborn
- Infant, Premature
- Infant, Very Low Birth Weight
- Leukomalacia, Periventricular -- diagnostic imaging
- Logistic Models
- Magnesium Sulfate -- pharmacology
- Odds Ratio
- Pre-Eclampsia -- drug therapy
- Pregnancy
- Pregnancy Complications, Cardiovascular -- drug therapy
- Prospective Studies
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.